Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Chemical Research in Toxicology

• Publication date

  2016-03-14

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1021/acs.chemrestox.6b00043PMID 26974882
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Comprehensive Insight into the Chemical Space and ADME Features of Small Molecule NS5A Inhibitors.

  2016cited by this paper
• Reactive Metabolites: Current and Emerging Risk and Hazard Assessments.

  2016cited by this paper
• Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone?

  2016cited by this paper
• How Beyond Rule of 5 Drugs and Clinical Candidates Bind to Their Targets.

  2016cited by this paper
• SAR Exploration Guided by LE and Fsp(3): Discovery of a Selective and Orally Efficacious RORγ Inhibitor.

  2016cited by this paper
• Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666.

  2016cited by this paper
• Strain-release amination

  2016cited by this paper
• 2015 FDA drug approvals

  2016cited by this paper
• Species differences in metabolism of EPZ015666, an oxetane-containing protein arginine methyltransferase-5 (PRMT5) inhibitor

  2016cited by this paper
• Optimizing Ligand Efficiency of Selective Androgen Receptor Modulators (SARMs).

  2016cited by this paper
• Probabilistic Approach to Generating MPOs and Its Application as a Scoring Function for CNS Drugs.

  2016cited by this paper
• Discovery of (3-(4-(2-Oxa-6-azaspiro[3.3]heptan-6-ylmethyl)phenoxy)azetidin-1-yl)(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)methanone (AZD1979), a Melanin Concentrating Hormone Receptor 1 (MCHr1) Antagonist with Favorable Physicochemical Properties.

  2016cited by this paper
• Ligand-Enabled γ-C(sp(3))-H Olefination of Amines: En Route to Pyrrolidines.

  2016cited by this paper
• Synthesis and Biopharmaceutical Evaluation of Imatinib Analogues Featuring Unusual Structural Motifs

  2016cited by this paper
• Molecular Property Design: Does Everyone Get It?

  2015cited by this paper
• Amorphous Solid Dispersions: Utilization and Challenges in Drug Discovery and Development.

  2015cited by this paper
• Discovery and Pharmacology of a Novel Class of Diacylglycerol Acyltransferase 2 Inhibitors.

  2015cited by this paper
• Oxidative Coupling between Two Hydrocarbons: An Update of Recent C-H Functionalizations.

  2015cited by this paper
• Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors.

  2015cited by this paper
• Molecular properties determining unbound intracellular and extracellular brain exposure of CNS drug candidates.

  2015cited by this paper
• Flexibility versus Rigidity for Orally Bioavailable Cyclic Hexapeptides

  2015cited by this paper
• Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case Study.

  2015cited by this paper
• Discovery and preclinical profiling of 3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitor.

  2015cited by this paper
• An analysis of the attrition of drug candidates from four major pharmaceutical companies

  2015cited by this paper
• Computational investigations of hERG channel blockers: New insights and current predictive models.

  2015cited by this paper
• Drug–Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir

  2015cited by this paper
• From scientific discovery to cures: bright stars within a galaxy.

  2015cited by this paper
• Preclinical Pharmacokinetics and In Vitro Metabolism of Asunaprevir (BMS-650032), a Potent Hepatitis C Virus NS3 Protease Inhibitor.

  2015cited by this paper
• Ligand efficiency metrics: why all the fuss?

  2015cited by this paper
• Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic Stability.

  2015cited by this paper
• A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design.

  2015cited by this paper
• Cheminformatic comparison of approved drugs from natural product versus synthetic origins.

  2015cited by this paper
• CNS drug design: balancing physicochemical properties for optimal brain exposure.

  2015cited by this paper
• Multi-parameter optimization of aza-follow-ups to BI 207524, a thumb pocket 1 HCV NS5B polymerase inhibitor. Part 2: Impact of lipophilicity on promiscuity and in vivo toxicity.

  2015cited by this paper
• Recent advances in the development of acetyl-CoA carboxylase (ACC) inhibitors for the treatment of metabolic disease.

  2015cited by this paper
• Transition metal catalyzed meta-C-H functionalization of aromatic compounds.

  2015cited by this paper
• Cell-permeable cyclic peptides from synthetic libraries inspired by natural products.

  2015cited by this paper
• Discovery and Optimization of Imidazopyridine-Based Inhibitors of Diacylglycerol Acyltransferase 2 (DGAT2).

  2015cited by this paper
• Structure-Based Drug Design of Novel Potent and Selective Tetrahydropyrazolo[1,5-a]pyrazines as ATR Inhibitors.

  2015cited by this paper
• The current state of drug discovery and what it might take to improve drug discovery outcomes and approval successes.

  2015cited by this paper
• ATM and ATR as therapeutic targets in cancer.

  2015cited by this paper
• What does it take to produce a breakthrough drug?

  2015cited by this paper
• Asunaprevir: A Review of Preclinical and Clinical Pharmacokinetics and Drug–Drug Interactions

  2015cited by this paper
• Improving R&D productivity

  2015cited by this paper
• Aza follow-ups to BI 207524, a thumb pocket 1 HCV NS5B polymerase inhibitor. Part 1: Mitigating the genotoxic liability of an aniline metabolite.

  2015cited by this paper
• 2014 FDA drug approvals

  2015cited by this paper
• Discovery of Selective Small Molecule Inhibitors of Monoacylglycerol Acyltransferase 3.

  2015cited by this paper
• Synthesis of new 4-phenylpyrimidine-2(1H)-thiones and their potency to inhibit COX-1 and COX-2.

  2015cited by this paper
• From non-A, non-B hepatitis to hepatitis C virus cure.

  2015cited by this paper
• Why is it hard to terminate failing projects in pharmaceutical R&D?

  2015cited by this paper
• Analysis of Physicochemical Properties for Drugs of Natural Origin.

  2015cited by this paper
• The cross-dehydrogenative coupling of C(sp3)-H bonds: a versatile strategy for C-C bond formations.

  2014cited by this paper
• Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates.

  2014cited by this paper
• Improving the plausibility of success with inefficient metrics.

  2014cited by this paper
• Recent trends in Pd-catalyzed remote functionalization of carbonyl compounds.

  2014cited by this paper
• The development speed paradox: can increasing development speed reduce R&D productivity?

  2014cited by this paper
• Two- and Three-dimensional Rings in Drugs

  2014cited by this paper
• Ligand efficiency metrics considered harmful

  2014cited by this paper
• Validity of ligand efficiency metrics.

  2014cited by this paper
• Discovery and early clinical evaluation of BMS-605339, a potent and orally efficacious tripeptidic acylsulfonamide NS3 protease inhibitor for the treatment of hepatitis C virus infection.

  2014cited by this paper
• The Role of Lymphatic Transport on the Systemic Bioavailability of the Bcl-2 Protein Family Inhibitors Navitoclax (ABT-263) and ABT-199

  2014cited by this paper
• Discovery and development of hepatitis C virus NS5A replication complex inhibitors.

  2014cited by this paper
• The Discovery of Potent Nonstructural Protein 5A (NS5A) Inhibitors with a Unique Resistance Profile—Part 2

  2014cited by this paper
• New hepatitis C therapies: the toolbox, strategies, and challenges.

  2014cited by this paper
• Clinical development success rates for investigational drugs

  2014cited by this paper
• Hepatitis C virus NS5A replication complex inhibitors: the discovery of daclatasvir.

  2014cited by this paper
• Discovery of novel pyrimidine and malonamide derivatives as TGR5 agonists.

  2014cited by this paper
• Preclinical pharmacokinetics and in vitro metabolism of BMS-605339: a novel HCV NS3 protease inhibitor.

  2014cited by this paper
• Physicochemical descriptors of aromatic character and their use in drug discovery.

  2014cited by this paper
• Bioactivation potential of thiophene-containing drugs.

  2014cited by this paper
• Design and Synthesis of High Affinity Inhibitors of Plasmodium falciparum and Plasmodium vivax N-Myristoyltransferases Directed by Ligand Efficiency Dependent Lipophilicity (LELP)

  2014cited by this paper
• Discovery of innovative therapeutics: today's realities and tomorrow's vision. 2. Pharma's challenges and their commitment to innovation.

  2014cited by this paper
• Potent cholesteryl ester transfer protein inhibitors of reduced lipophilicity: 1,1'-spiro-substituted hexahydrofuroquinoline derivatives.

  2014cited by this paper
• The Discovery of Potent Nonstructural Protein 5A (NS5A) Inhibitors with a Unique Resistance Profile—Part 1

  2014cited by this paper
• The role of ligand efficiency metrics in drug discovery

  2014cited by this paper
• Update on the discovery and development of cholesteryl ester transfer protein inhibitors for reducing residual cardiovascular risk.

  2014cited by this paper
• Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals.

  2014cited by this paper
• Rings in drugs.

  2014cited by this paper
• Preclinical research: Make mouse studies work

  2014cited by this paper
• “Effect of the drug transporters ABCB1, ABCC2, and ABCG2 on the disposition and brain accumulation of the taxane analog BMS-275,183”

  2014cited by this paper
• Novel tactics for designing water-soluble molecules in drug discovery

  2014cited by this paper
• The discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infection.

  2014cited by this paper
• Curing chronic hepatitis C--the arc of a medical triumph.

  2014cited by this paper
• Improving productivity of modern-day drug discovery

  2014cited by this paper
• Does size matter in R&D productivity? If not, what does?

  2013cited by this paper
• Trial Watch: Phase II and Phase III attrition rates 2011–2012

  2013cited by this paper
• Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.

  2013cited by this paper
• Lipophilic efficiency: the most important efficiency metric in medicinal chemistry.

  2013cited by this paper
• Impact of physicochemical profiling for rational approach on drug discovery.

  2013cited by this paper
• Evaluating the differences in cycloalkyl ether metabolism using the design parameter "lipophilic metabolism efficiency" (LipMetE) and a matched molecular pairs analysis.

  2013cited by this paper
• Is poor research the cause of the declining productivity of the pharmaceutical industry? An industry in need of a paradigm shift.

  2013cited by this paper
• Are hERG channel blockers also phospholipidosis inducers?

  2013cited by this paper
• The development of CNS-active LRRK2 inhibitors using property-directed optimisation.

  2013cited by this paper
• Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor.

  2013cited by this paper
• Taxanes: old drugs, new oral formulations.

  2013cited by this paper
• Efficient Stacking on Protein Amide Fragments

  2013cited by this paper
• Inflation of correlation in the pursuit of drug-likeness

  2013cited by this paper
• Drug dissolution: significance of physicochemical properties and physiological conditions.

  2013cited by this paper
• 3D Molecular Descriptors Important for Clinical Success

  2013cited by this paper
• Model‐Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development

  2013cited by this paper

• Thiazole scaffolds as anticancer and antimicrobial agents: recent advances in medicinal chemistry.

  2026cites this paper
• Synthesis of 1,3-Alkylphosphoryl Bicyclo[1.1.1]pentane by Photocatalytic Cascade Radical Addition.

  2026cites this paper
• Novel Scaffold Unlocks Potent Cross-Peptidase and Cross-Species Inhibitors as Promising Antimalarial Agents.

  2026cites this paper
• Strain-Release Diversification of 1-Azabicyclobutanes via Bromide/Nickel Relay Catalyzed 1,3-Bis-Carbofunctionalization.

  2026cites this paper
• Structure-Based Virtual Screening Discovers Potent PLK1 Inhibitors with Anticancer Activity.

  2026cites this paper
• Modular Synthesis of Densely Functionalized Azetidines: Ni-Catalyzed 1,4-Alkylarylation of 1,3-Enynes with 1-Azabicyclo[1.1.0]butanes through Polar-Radical Relay.

  2026cites this paper
• Collective synthesis of 1,2,4-trisubstituted, meta- and ortho-substituted arene bioisosteres from bicyclobutanes.

  2026cites this paper
• In-silico molecular properties and bioactivity of potential drug leads of bioactive compounds from the genus Salvia and Sapium

  2026cites this paper
• Isolation, structural characterisation and in silico evaluation of new biflavonoids from Ficus racemosa L.

  2026cites this paper
• Retro aza-[2+2] cycloaddition as stereochemical editing logic for multi-substituted azacyclobutanes

  2025cites this paper
• Fluorenyl-phthalimide hybrids as potent aldose reductase inhibitors with selective anticancer activity: Rational design, synthesis, and molecular insights.

  2025cites this paper
• In silico screening, ADMET analysis and computational simulation studies on Garcinia indica Choisy phytoconstituents as prospective antibreast cancer agents: a critical appraisal of the neglected plant

  2025cites this paper
• Large Language Models for Controllable Multi-property Multi-objective Molecule Optimization

  2025cites this paper
• Bayesian illumination: Inference and quality-diversity accelerate generative molecular models

  2025cites this paper
• Catalytic Asymmetric Synthesis of Chiral Caged Hydrocarbons as Arenes Bioisosteres.

  2025cites this paper
• Photocatalytic Difunctionalization of [1.1.1]Propellane

  2025cites this paper
• Applications of Bridgehead Heterocycles in Drug Design and Medicinal Chemistry

  2025cites this paper
• Modular Synthesis of 3,3-Disubstituted Azetidines via Azetidinylation Reagents.

  2025cites this paper
• Visible light induced synthesis of the Benzoyl bioisosteres: bicyclo[1.1.1]pentane-ketone group

  2025cites this paper
• Electron Donor-Acceptor (EDA) Complex-Driven Activation of N-α C—H Bonds

  2025cites this paper
• Synthesis of bicyclo[3.1.1]heptanes, meta-substituted arene isosteres, from [3.1.1]propellane

  2025cites this paper
• A Mini-Review on Pyridine—A Versatile Compound in the Field of Therapeutic Agents

  2025cites this paper
• Highly Functional Allyl-Bicyclo[1.1.1]pentane Synthesis by Radical-Initiated Three-Component Stereoselective Allylation

  2025cites this paper
• Synthesis, Antiprotozoal Activity, and Physicochemical Evaluation of Benzamido–Menadione Derivatives

  2025cites this paper
• Triply convergent Ni-electrocatalytic assembly of 1,1-diaryl cyclobutanes, azetidines and oxetanes

  2025cites this paper
• Synthetic Developments and Functionalization Approaches for Bicyclo[1.1.1]pentanes via [1.1.1]Propellane

  2025cites this paper
• Diastereo- and enantioselective 1,3-hydrofunctionalization of trisubstituted alkenes by a directing relay

  2025cites this paper
• Design, synthesis, biological and computational evaluation of novel S/N-glycerolyl and peptide-conjugated [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potent CDK2 inhibitors for anticancer therapy.

  2025cites this paper
• Trimethoxyphenyl-1,2,4-triazol-3-ones: synthesis, characterization, DFT, antimicrobial and acetylcholinesterase inhibitory activities with molecular docking and dynamics studies

  2025cites this paper
• Metallaphotoredox-Catalyzed Cross-Electrophile Couplings of Aryl Chlorides and Alkyl Halides: Harnessing the σ-Donor/π-Acceptor Synergy of a 2-(1H-Imidazol-2-yl) pyridine Ligand.

  2025cites this paper
• Unveiling Vibrational Couplings in Model Peptides in Solution by a Theoretical Approach

  2025cites this paper
• α-Amino bicycloalkylation through organophotoredox catalysis

  2024cites this paper
• Harnessing Oxetane and Azetidine Sulfonyl Fluorides for Opportunities in Drug Discovery

  2024cites this paper
• Advancing mitochondrial therapeutics: Synthesis and pharmacological evaluation of pyrazole-based inhibitors targeting the mitochondrial pyruvate carrier

  2024influential citation
• Discovery of α-amylase and α-glucosidase dual inhibitors from NPASS database for management of Type 2 Diabetes Mellitus: A chemoinformatic approach

  2024cites this paper
• Visible-light photoredox-catalyzed three-component radical alkyl-acylation of [1.1.1]propellane.

  2024cites this paper
• Chemoinformatic Characterization of NAPROC-13: A Database for Natural Product 13C NMR Dereplication

  2024cites this paper
• Halogen Bonding Initiated Difunctionalization of [1.1.1]Propellane via Photoinduced Polarity Match Additions.

  2024cites this paper
• Searching for "Greener" Bioequivalents of CF3 to Lower its Environmental Impact.

  2024cites this paper
• Lewis acid catalyzed [4+2] annulation of bicyclobutanes with dienol ethers for the synthesis of bicyclo[4.1.1]octanes

  2024cites this paper
• Recent Advances in the Domino Annulation Reaction of Quinone Imines

  2024cites this paper
• Synthesis of 1-(Halo)alkyl-3-heteroaryl Bicyclo[1.1.1]pentanes Enabled by a Photocatalytic Minisci-type Multicomponent Reaction

  2024cites this paper
• Photoinduced C(sp3)-H Bicyclopentylation Enabled by an Electron Donor-Acceptor Complex-Mediated Chemoselective Three-Component Radical Relay.

  2024cites this paper
• The role of the methoxy group in approved drugs.

  2024cites this paper
• Navigating the Chemical Space of ENR Inhibitors: A Comprehensive Analysis

  2024cites this paper
• A new synthetic route towards multifunctionalized cyclic amidrazones for feeding chemical space.

  2024cites this paper
• C−F bond activation enables synthesis of aryl difluoromethyl bicyclopentanes as benzophenone-type bioisosteres

  2024cites this paper
• Selective androgen receptor modulator use and related adverse events including drug-induced liver injury: Analysis of suspected cases

  2023cites this paper
• Discovery of a Hydroxylamine-Based Brain-Penetrant EGFR Inhibitor for Metastatic Non-Small-Cell Lung Cancer

  2023cites this paper
• Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson's Disease.

  2023cites this paper
• Bicyclo[m.n.k]alkane Building Blocks as Promising Benzene and Cycloalkane Isosteres: Multigram Synthesis, Physicochemical and Structural Characterization.

  2023cites this paper
• Azetidines with All-Carbon Quaternary Centers: Merging Relay Catalysis with Strain Release Functionalization.

  2023cites this paper
• Unveiling Mechanistic Insights and Photocatalytic Advancements in Intramolecular Photo-(3 + 2)-Cycloaddition: A Comparative Assessment of Two Paradigmatic Single-Electron-Transfer Models

  2023cites this paper
• Ruthenium complexes for breast cancer therapy

  2023cites this paper
• Reflections on a 40-year career in drug design and discovery

  2023cites this paper
• A general organophotoredox strategy to difluoroalkyl bicyclo-alkane (CF2-BCA) hybrid bioisosteres.

  2023cites this paper
• Harnessing the necessary nitrogen atom in chemical biology and drug discovery

  2023cites this paper
• Conquering the Synthesis and Functionalization of Bicyclo[1.1.1]pentanes

  2023cites this paper
• Molecular Dynamics Simulation Studies of Bile, Bile Salts, Lipid-Based Drug Formulations, and mRNA-Lipid Nanoparticles: A Review.

  2023cites this paper
• Trends in Molecular Properties, Bioavailability, and Permeability across the Bayer Compound Collection.

  2023cites this paper
• Incorporation of an Isohexide Subunit Improves the Drug-like Properties of Bioactive Compounds.

  2023cites this paper
• Synthesis of meta-substituted arene bioisosteres from [3.1.1]propellane

  2022cites this paper
• In Silico Positional Analogue Scanning with Amber GPU-TI

  2022cites this paper
• Photoredox Deaminative Alkylation in DNA-Encoded Library Synthesis.

  2022cites this paper
• LipMetE (Lipophilic Metabolism Efficiency) as a Simple Guide for Half-Life and Dosing Regimen Prediction of Oral Drugs.

  2022cites this paper
• In silico Investigation of inhibitory characteristics of phytoconstituents from Moringa oleifera against SARS-CoV-2 viral proteins

  2022cites this paper
• In silico Investigation of inhibitory characteristics of phytoconstituents from Moringa oleifera against SARS-CoV-2 viral proteins

  2022cites this paper
• Structure-Based Virtual Screening Towards The Discovery of Usnic Acid Derivatives as Novel mTOR Inhibitor to Treat Breast Cancer

  2022cites this paper
• Competitive Displacement Restores the Hyperpolarized 15N NMR Signal in Blood Plasma

  2022cites this paper
• The Impact of Software Used and the Type of Target Protein on Molecular Docking Accuracy

  2022cites this paper
• Skeleton-Reorganizing Coupling Reactions of Cycloheptatriene and Cycloalkenones with Amines.

  2022cites this paper
• Ni-Catalyzed Reductive Cross-Coupling of Cyclopropylamines and Other Strained Ring NHP Esters with (Hetero)Aryl Halides.

  2022cites this paper
• Advances in nonclassical phenyl bioisosteres for drug structural optimization.

  2022cites this paper
• The Role of Natural Products as Sources of Therapeutic Agents for Innovative Drug Discovery

  2022cites this paper
• Four‐Component Strain‐Release‐Driven Synthesis of Functionalized Azetidines

  2022cites this paper
• The Time and Place for Nature in Drug Discovery

  2022cites this paper
• Rapid and Scalable Halosulfonylation of Strain‐Release Reagents

  2022cites this paper
• Identification of Small Molecules with Improved Potency against Orthopoxviruses from Vaccinia to Smallpox

  2022cites this paper
• Target-based evaluation of ‘drug-like’ properties and ligand efficiencies

  2021cites this paper
• Skipped Fluorination Motifs: Synthesis of Building Blocks and Comparison of Lipophilicity Trends with Vicinal and Isolated Fluorination Motifs.

  2021cites this paper
• Analogue discovery of safer alternatives to HCQ and CQ drugs for SAR-CoV-2 by computational design

  2021cites this paper
• Flavonol morin targets host ACE2, IMP-α, PARP-1 and viral proteins of SARS-CoV-2, SARS-CoV and MERS-CoV critical for infection and survival: a computational analysis

  2021cites this paper
• Divergent, Strain‐Release Reactions of Azabicyclo[1.1.0]butyl Carbinols: Semipinacol or Spiroepoxy Azetidine Formation

  2021cites this paper
• Carbamate and N-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 Inhibitors.

  2021cites this paper
• Use of the Complementarity Principle in Docking Procedures: A New Approach for Evaluating the Correctness of Binding Poses

  2021cites this paper
• Put a ring on it: application of small aliphatic rings in medicinal chemistry.

  2021cites this paper
• Discovery of Potent Coumarin-Based Kinetic Stabilizers of Amyloidogenic Immunoglobulin Light Chains Using Structure-Based Design.

  2021cites this paper
• Azatricyclic Inverse Agonists of RORγt That Demonstrate Efficacy in Models of Rheumatoid Arthritis and Psoriasis.

  2021cites this paper
• Identification of 3-Methoxycarpachromene and Masticadienonic Acid as New Target Inhibitors against Trypanothione Reductase from Leishmania Infantum Using Molecular Docking and ADMET Prediction

  2021cites this paper
• Drug Discovery Beyond the Rule of Five

  2021cites this paper
• Recent Advances in Chemistry Technologies and Applications to Medicinal Chemistry

  2021cites this paper
• Synthesis and reactions of ω-CF3O-substituted aliphatic sulfonyl chlorides

  2021cites this paper
• Geminal Diheteroatomic Motifs: Some Applications of Acetals, Ketals, and Their Sulfur and Nitrogen Homologues in Medicinal Chemistry and Drug Design.

  2021cites this paper
• ChemBead Enabled High-Throughput Cross-Electrophile Coupling Reveals a New, Complementary Ligand.

  2021cites this paper
• Computational study for identifying promising therapeutic agents of hydroxychloroquine analogues against SARS‐CoV‐2

  2021cites this paper
• Bioisosteres of the Phenyl Ring: Recent Strategic Applications in Lead Optimization and Drug Design.

  2021cites this paper
• 1,5-Benzodiazepin-2(3H)-ones: In Vitro Evaluation as Antiparkinsonian Agents

  2021cites this paper
• Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases.

  2021cites this paper
• Natural product drug discovery in the artificial intelligence era

  2021cites this paper
• Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors.

  2021cites this paper